Ornish et al. — Prostate Cancer Progression Halted by Lifestyle Intervention (2005)

Dean Ornish, Peter Carroll, and colleagues at UCSF conducted the first randomized controlled trial of lifestyle intervention in prostate cancer, published in the Journal of Urology in September 2005. The trial enrolled 93 men with biopsy-confirmed prostate cancer who had elected active surveillance (watchful waiting), randomly assigning them to a comprehensive lifestyle program or a comparison group.

The lifestyle intervention included a whole-food vegan diet, 30 minutes of daily walking six days per week, one hour of daily meditation, and nutritional supplementation (soy, fish oil, vitamins E, C, selenium). After one year, PSA decreased 4% in the experimental group versus a 6% increase in controls. Prostate cancer cell growth was inhibited approximately 8-fold more in the experimental group in an in vitro serum assay. No men in the experimental group required conventional treatment at one year.

Relevance to This Dataset

This case is included as a scientifically rigorous secular anchor. It demonstrates that documented cancer modification — not merely anecdotal improvement — can occur through biological pathways that are well-defined (dietary, hormonal, immunological). That context matters for evaluating cases in this dataset where "medically inexplicable" is claimed: the baseline of what lifestyle and immune factors can achieve is higher than intuition suggests.

Limitation

PSA is a surrogate marker, not a tumor endpoint. The study does not document biopsy-confirmed tumor regression. It establishes measurable biological modification of cancer trajectory, not remission.